Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
MAPTO Survey Reveals Global Variability in Managing FVIII Inhibitors in Children on Emicizumab – JTH
First author of the article - Lilianne van Stam/LinkedIn
Mar 30, 2026, 17:27

MAPTO Survey Reveals Global Variability in Managing FVIII Inhibitors in Children on Emicizumab – JTH

Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Lilianne van Stam et al, adding:

”The MAPTO Survey: Worldwide Approaches on Unmasking Factor VIII Inhibitors in Children with Emicizumab Treatment

A global survey of 102 healthcare providers across 38 countries reveals highly heterogeneous practices regarding FVIII inhibitor risk assessment and concomitant FVIII use in previously untreated hemophilia A children on emicizumab, underscoring the urgent need for evidence-based treatment guidelines.”

Title: The MAPTO survey: worldwide approaches on unmasking factor VIII inhibitors in children with emicizumab treatment: communication from the ISTH SSC Subcommittee on Factor VIII, Factor IX and Rare Coagulation Disorders

Authors: Lilianne van Stam, Bridget Horstman, Pantep Angchaisuksiri, Manuel Carcao, Gili Kenet, Christoph Königs, Johnny Mahlangu, Maria Mancuso, Suely Rezende, Robert Sidonio, Alok Srivastava, Guy Young, Karin Fijnvandraat, Samantha Gouw

Read the Full Article on JTH

MAPTO Survey Reveals Global Variability in Managing FVIII Inhibitors in Children on Emicizumab - JTH

Stay updated on all scientific advances with Hemostasis Today.

Alok Srivastava Bridget Horstman children Christoph Königs Emicizumab Factor VIII Gili Kenet Guy Young Hemophilia Johnny Mahlangu JTH Karin Fijnvandraat Lilianne van Stam Manuel Carcao MAPTO Maria Mancuso Pantep Angchaisuksiri Robert Sidonio Samantha Gouw Suely Rezende
NewsFeed